Introduction
Various results suggest that the growth of AML cells is controlled by cytokines produced by the leukemic cells in an autocrine or paracrine way. Unlike normal hematopoietic cells, leukemic blasts from many patients with AML constitutively express cytokines like GM-CSF, G-CSF, IL1, IL6, IL8, TNFa and SCF [1] [2] [3] [4] . Moreover, the expression of hematopoietic growth factor genes in AML cells is modulated by cytokines [5, 6] . AML cells frequently bear receptor molecules for G-CSF, GM-CSF, TNFa, IL1, IL3, IL6, SCF [7] [8] [9] [10] [11] and proliferate in response to exogenous growth factors both in vitro and in vivo [12] [13] [14] [15] [16] . A fraction of cases will use these molecules to support clonogenic growth in an autocrine or paracrine way [1, 17] .
IL10 is a pleiotropic cytokine which is produced by a variety of cells including T-cells, macrophages, Lyl positive B-cells, EBV positive B-cells, mast cells and keratinocytes [18] . IL10 inhibits the expression of cytokines in activated macrophages most likely at the transcriptional level [19, 20] . TL10 also inhibits proliferation and cytokine secretion of TH1 cells. On the other hand, IL10 stimulates the proliferation and differentiation of activated B-cells and TH2 cells. This results in an amplification of the humoral immune response with elevated secretion of IgM, IgA and IgG [21, 22] . Moreover, IL10 increases the formation of multilineage colonies containing erythrocytes, megakaryocytes, and mast cells, but it has no effect on the growth of eosinophil, neutrophil and macrophage progenitors [23] .
Since IL10 has been shown to regulate proliferation and cytokine production in normal hematopoietic cells, we analysed whether this cytokine has an effect on the growth control of malignant myeloid cells. Our results demonstrate that IL10 drastically inhibits cytokine secretion, mRNA expression and DNA synthesis of AML cells in vitro.
Materials and methods

AML cells
Blood and bone marrow were obtained by routine diagnostic aspirates from 18 de novo AML patients referred to the Klinik I fur Innere Medizin, Universitat Koln. AML cells were identified according to morphological and cytochemical criteria based on French-American-British criteria [24] (Table 1) . Patients were treated following the protocols of the BMFT study group.
Immunostaining
The expression of surface antigens was analysed by staining with fluorescein-or phycoerythrin-conjugated monoclonal antibodies specific for CD3, CD4, CD5, CDllb, CDllc, CD14, CD15, CD19, CD33, CD34, CD38, CD71 and HLA-DR (Becton-Dickinson, Mountain View, CA). Cells (1 x lOVtest) were incubated with the Ml  M2  M2  M2  M2  M2  M4  M4  M4  M4  M4  M4  M4  M4  M4  M5a  TLD  TLD   BM  BM  PB  PB  PB  PB  BM  PB  PB  PB  PB  PB  BM  PB  BM  BM  PB  PB   91  92  94  96  95  92  91  98  100  91  95  90  92  90  94  96  95  94   CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,  CD38,   CD71, CD34  CD33, CD71  CD33, HLA-DR, CD71, CDllc, CD15  CD33, HLA-DR, CD71, CD34, CDllc  CD33, HLA-DR, CD71, CD34, CDllc, CD15  CD33, HLA-DR, CD71, CD15  CD33, CDllb, HLA-DR, CD71, CDllc, CD14, CD15  CD33, HLA-DR, CD71, CD34, CDllc, High-gradient magnetic cell separation After Ficoll-Paque gradient centrifugation, T-cells and monocytes were depleted using the high-gradient cell separation technique (MACS) [25] . Briefly, T-lymphocytes were labeled with anti-CD3 antibodies and monocytes with anti-CD 14 antibodies coupled to magnetic beads. Labeled and unlabeled cells were separated in a high-gradient magnetic field which was generated in a column of coated steelwool inserted into the MACS magnet Staining and separation was controlled on a FACScan flow cytometer. After MACS separation less than 1% contaminating CD3 and CD14 positive cells were detected, with 90%-100% AML blasts ( Table 1) . Depletion of CD 14 positive cells was not performed in cases with AML M4 and AML M5 expressing the CD14 antigen.
Cell culture AU cultures were performed in DMEM medium supplemented with 5% albumax, non essential amino acids, L-glutamin, MEM-vitamine solution (all from Gibco Berlin, Germany) and ciprofloxacin (5 ng/ ml) (Bayer Leverkusen, Germany). Cells (5 x lOVml) were plated with cytokines in 96 well flat bottom microtiter plates (Greiner, Germany) in triplicate cultures. Human IL10 was a gift from Dr. de Vries (DNAX Palo Alto, USA.). Recombinant GM-CSF was provided by Behring AG, Marburg, G-CSF from Amgen, Munich, IL9 was a gift of Dr. Feller, Liibeck; SCF was obtained from Genzyme, Cambridge, USA., IL2 and IL6 from Gibco (Berlin, Germany); IL3 and IL4 from Pharma Biotechnology (Hannover, Germany). Cytokines were added to purified AML cells at concentrations between 1 to 100 U/ml. DNA synthesis of cultured AML cells (1 x lOVwell) was monitored by 3 H-thymidine incorporation (0.4 |iCi/well Amersham Buchler, Braunschweig, Germany) during the last 16 hours of culture. Cells were harvested and analysed by liquid scintillation counting (Beckmann, Diisseldorf, Germany). Data are presented as the mean cpm + standard deviation of triplicate measurements. Parallel cultures were analysed for production of cytokines by ELISA. Supernatants of these cultures were harvested after 3 days of culture.
Colony assays were performed with and without additional growth factors (ILip, GM-CSF and IL3) and IL10 in 1.3% methylcellulose in IMDM, 20% FCS, 50 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 U/ml streptomycin and 2 mM L-glutamine at 37 'C in a fully humidified atmosphere. Colony growth was scored on day 14 [26] .
DNA synthesis and production of cytokines by AML cells was also analysed in the presence of neutralizing anti-ILlO antibodies (clone JES3-12G8, PharMingen, San Diego, USA.) at a concentration of 1 ng/ml. The Student's test was used to test the probability of significant differences between samples (P < 0.01).
ELISA
ILla, IL10, IL3, IL6, SCF, IFNy, GM-CSF, TNFa and IL10 were measured in culture supernatants by ELISA. The assays were purchased from RD Systems (Minneapolis, USA.), and BioSource International (Camarillo, USA.), and performed according to the manufacturer's protocols. The sensitivity of the ELISA were as follows: GM-CSF 7.8 pg/ml, ILla 3.8 pg/ml, ILip 3.9 pg/ml, IL3 31 pg/ml, IL6 3.1 pg/ml, SCF 31 pg/ml, TNFa 15.6 pg/ml, IL10 15 pg/ml.
PCR analyses
Cytokine transcription was analysed by reverse transcription polymerase chain reaction as described [27) . Briefly, RNA was extracted from 1 x 10 3 cells by the acidic phenol/chloroform protocol [28] reversely transcribed with random primers using the Superscript-RT-polymerase (Gibco-BRL) according to the manufacturer and then analysed by PCR. The primer pairs are as follows: actin (5' cgggaaatcgtgcgtgacat; 3' gaactttgggggatgctcgc) generating a 712bp fragment from cDNA and 557bp from the control fragment, ILip (5' aaacagatgaagtgctccttccagg; 3' tggagaacaccacttgttgctcca) generating a 388bp fragment from cDNA, IL10 (5' ctgagaaccaagacccagacatcaagg; 3' caataaggtttctcaaggggctgg) generating a 351bp fragment from cDNA, TNFa (5' cagagggaagagttccccag; 3' ccttggtctggtaggagacg) generating a 325bp fragment from cDNA, GM-CSF (5' ctcgcccagccccagcacgc; 3' gcagctccccggcttggcca) generating a 411bp fragment from cDNA and 276bp from the control fragment.
The PCR-products were analysed by agarose gel electrophoresis (2% in 0.5 x Tris-borate-buffer).
Results
Cytokine production of cultured AML cells
T-cell and monocyte-depleted AML cells were cultured for 3 days under serum-free culture conditions. Subsequently, the DNA synthesis of the cells and the production of cytokines were analysed. The results are depicted in Table 2 . IL3, SCF and IFNy were not produced by any AML tested. Various concentrations of GM-CSF, ILip, TNFa and IL10 could be detected in some but not all AML. There was a correlation between the production of GM-CSF, ILip 1 and TNFa which were secreted concomitantly in 9/9 cases and were not detected in supernatants of 9 other cases ( Table 2) . AML cells, which showed spontaneous DNA uptake, produced significant levels of cytokines in contrast to AML cells without spontaneous proliferation 23  38  310  520  75  560  130  28  750  -_  _  ---_  --IL1-P   32  250  250  250  280  215  220  8  420  -_  _  --_  ---TNF-a   48  150  420  410  320  440  240  57  550 -
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( Table 2 ). These data suggest that the cytokines produced might be responsible for the spontaneous growth of AML cells in vitro, although a correlation between the levels of cytokines and DNA synthesis was not observed.
Stimulation of AML cells by cytokines
AML cells were stimulated with a panel of cytokines to analyse whether the DNA synthesis of the cells could be induced or suppressed by exogenous growth factors. 
Inhibition of AML cytokine production and DNA synthesis by IL10
When IL10 was added to AML cells a strong inhibition of cytokine expression and cell proliferation could be detected. Table 3 depicts the inhibition of DNA synthesis and cytokine production by IL10 in 9 AML with spontaneous in vitro growth. As shown in Figure 2 IL10 inhibited the expression of cytokines and the DNA synthesis of the cells in a dose-dependent way, with maximal inhibition between 10 and 100 U/ml. In this experiment synthesis of GM-CSF, LLip and TNFa was strongly reduced (Patient MW). As depicted in Figure 3, IL10 could also suppress the production of IL6 and ILla. Inhibition of cytokine production and DNA synthesis was detected in 9/9 cases of AML with spontaneous proliferation. In contrast, IL10 did not inhibit the spontaneous proliferation of two myeloid cell lines, HL60 and U937. Secretion of GM-CSF, ILip and TNFa could not be detected in the supernatants of HL60 and U937 (data not shown). IL10 at 10 to 100 U/ml failed to inhibit significantly colony formation by primary AML cells in 20% FCS containing methylcellulose cultures supported by a combination of growth factors (IL3, GM-CSF, ILip) (data not shown).
Anti-ILIO antibodies abrogate the inhibitory effect of IL10
To analyse whether the inhibitory effect of IL10 is specific, AML cells were cultured with IL10 and monoclonal IL10 specific antibodies. Figure 4 demonstrates that both the inhibition of cytokine (ILip 1 , GM-CSF and TNFa) production and DNA synthesis could be abrogated by monoclonal IL10 specific antibodies (patient CK). 
IL10 inhibits mRNA expression of GM-CSF and TNFa
Total RNA was extracted from leukemic blast cells cultured with or without LL10 and analysed for the presence of ILip, GM-CSF and TNFa by RT-PCR. Figure  5 shows an example of the expression of LLip, GM-CSF and TNFa transcripts. In order to quantify the cytokine transcripts, we used three-fold dilution steps of each mRNA in RT-PCR. mRNA for LL1 p, GM-CSF and TNFa were detected concomitantly in the cells cultured without LL10. During cell culture actin levels, which were taken to standardize RNA levels, were slightly diminished in LLlO-rreated cultures. Exposure 
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of AML cells to ILIO significantly reduced the expression of GM-CSF within the first 24 hours (line B2 vs. B12 for GM-CSF /taken into account the effect on actin expression in line A2 vs. A12). TNFa mRNA was reduced to a smaller extent after 72 hours (line D8 vs. D18 for TNFa/ line A8 vs. A18 for actin) incubation with IL10, whereas the ILip mRNA was not significantly diminished. These data suggest that IL10 inhibits the GM-CSF synthesis mainly through reduction of GM-CSF transcripts. In contrast to GM-CSF, a downregulation of ILip mRNA expression was not observed, indicating that the drastically reduced ILip production by IL10 is predominantly due to posttranscriptional regulation of ILip. IL10 transcripts were not detected in most analysed AML (15/18) in serumfree cultures after 35 cycles of PCR (data not shown).
Discussion
The proliferation of AML-derived blasts in culture requires the presence of one or more growth factors produced by the cells or added to the culture. In the majority of cases TNF-a, SCF, IL3, IL1 and GM-CSF stimulate clonogenic growth of AML blasts. Other factors like IL4, IL6 and G-CSF can synergise this effect [5, 14, 28, 29] . As indicated in Table 2 , there is a strong correlation between the production of ILip, GM-CSF and TNFa and spontaneous thymidine uptake. These data are in line with results obtained by other groups which demonstrate that production of ILip, GM-CSF and TNFa by AML blasts is coordinated and that neutralisation of GM-CSF, ILip or TNFa by specific antibodies inhibits spontaneous DNA synthesis [17, 28] . Beside these extracellular autocrine or paracrine loops, there is evidence for intracellular autocrine loops involving cytokines, which may contribute to the regulation of growth in AML cells. This internal autocrine regulation was refractory to neutralizing antibodies to the relevant cytokines or ILIRa and could be inhibited by antisense oligonucleotides [30] . Intracellular autocrine loops might be responsible for difference between the levels of secreted cytokines and spontaneous DNA synthesis.
Our results clearly demonstrate that IL10 can strongly inhibit thymidine uptake of cultured AML cells in a dose-dependent way. This suppressive effect might occur through inhibition of cytokine production, which could be demonstrated in all cases with spontaneous proliferation (Table 3) . Exposure to ILIO reduced mRNA expression of GM-CSF and TNFa in purified AML cells. Our data suggest that IL10 acts at transcriptional level, especially in the regulation of GM-CSF. Similar to these results, it has been shown that ILIO inhibits proliferation and cytokine production in LPS stimulated normal mononuclear cells [20] ; nuclear run-on experiments demonstrated that IL10 inhibited transcription of ILip, IL6 and TNFa [31] . In our studies, a regulation of ILip mRNA expression in AML cells was not observed, indicating that the drastically reduced IL1 p synthesis by ILIO is not due to transcriptional regulation. As described previously, overexpression of colony stimulating factors in AML is partially mediated through posttranscriptional stabilization of mRNA [32] . The different effect of ILIO on the cytokine secretion and the mRNA expression of ILip suggests that IL10 in AML also acts at postranscriptional level.
ILIO did not inhibit growth of the established AML cell lines HL60 and U937. In these lines, TNFa, ILip and GM-CSF could not be detected in the supernatant. These data suggest that the inhibitory effect of ILIO is dependent on cell growth induced by distinct cytokines.
Growth of AML can also be inhibited by other cytokines like ILIRa, TGFp\ MTP-la or IL4 [33] [34] [35] [36] . TGFp inhibited cytokine induced growth of AML cells by downregulation of cytokine receptor expression [37] MlP-la prevented AML progenitors from entering the proliferative phase of the cell cycle, whereas it had no effect on IL-ip levels [35] . In addition, ILIO acts predominantly on spontaneously growing AML cells, while on the other hand TGFP and IL4 required stimulation with exogenous growth factors to show its inhibitory effect [37, 38] . IL1R antagonist was shown to inhibit the spontaneous as well as ILl-stimulated AML proliferation and additionally reduced the amount of GM-CSF in culture supernatants of AML cells [39] . Interestingly, ILIO stimulates the IL1R antagonist in activated macrophages [40] . Whether ILIO is involved in ILIRa induction in AML cells is currently object of further studies.
Since cytokines like ILip, GM-CSF and TNFa are produced by AML blasts and may provide neoplastic cells with a growth advantage in an autocrine or paracrine way, the inhibition of AML cytokine release and cell growth could have clinical relevance. The growth inhibition might open an alternative or additional approach to chemotherapy by inhibition of the proliferating fraction of AML cells in the absence of cytotoxic drugs [2, 41, 42] . It has been shown that IL10 has the capacity to prevent the onset of septic shock in mice given a lethal dose of lipopolysaccharide [43] , presumably through inhibition of cytokines such as TNFa. Since TNFa may be involved in septic shock in humans, IL10 could be of benefit especially for those patients suffering from AML and systemic infections.
